Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,437,135
-
Number of holders
-
160
-
Total 13F shares, excl. options
-
48,764,141
-
Shares change
-
+1,772,443
-
Total reported value, excl. options
-
$1,672,916,979
-
Value change
-
+$32,659,099
-
Put/Call ratio
-
119%
-
Number of buys
-
86
-
Number of sells
-
-80
-
Price
-
$34.32
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q4 2018
215 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock as of Q4 2018.
PTC THERAPEUTICS, INC. - Common Stock (PTCT) has 160 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48,764,141 shares
of 80,437,135 outstanding shares and own 60.62% of the company stock.
Largest 10 shareholders include Vanguard Group Inc (4,596,105 shares), BlackRock Inc. (3,707,241 shares), FRANKLIN RESOURCES INC (3,214,293 shares), FMR LLC (2,802,517 shares), PRICE T ROWE ASSOCIATES INC /MD/ (2,752,246 shares), STATE STREET CORP (2,398,314 shares), BOXER CAPITAL, LLC (2,155,000 shares), RTW INVESTMENTS, LP (1,922,346 shares), CITADEL ADVISORS LLC (1,780,053 shares), and SCOPIA CAPITAL MANAGEMENT LP (1,626,965 shares).
This table shows the top 160 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.